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ABSTRACT
Multiple sclerosis affects the lower urinary tract in many patients. The relationship between  
lower urinary tract abnormalities and disease-related parameters of multiple sclerosis is not well 
described. We screened urologically and neurologically 212 patients according to a standard  
protocol. Micturition complaints were noted in 52% of the patients and urodynamic abnormalities 
were found in 64%. A statistical correlation was found between detrusor hyperactivity and  
detrusor hypoactivity with disease-related parameters, that is disease duration, disability status, 
m yelin basic protein concentration in the cerebrospinal fluid and neurophysiological investiga­
tions. No relationship was found between detrusor hypersensibility or detrusor hyposensibility  
and the aforementioned disease-related parameters. In 1 patient upper urinary tract abnormal­
it ies  were noted in combination with urodynamic abnormalities. We conclude that lower urinary 
tract abnormalities can be found in every patient with multiple sclerosis unrelated to the state  
of the disease. Severe upper urinary tract abnormalities are rare.
Key Words; multiple sclerosis, urination disorders, urodynamics, urinary incontinence
Multiple sclerosis is a disease in which most of the patho­
logical and clinical features can be related to the destruction 
and loss of a single type of cell, the myelin-producing oligo­
dendrocyte.1 This destruction results in decreased nerve con­
duction in the central nervous system and in varying neuro­
logical abnormalities, which tend to remit and exacerbate 
with time.2 Among the many different signs and symptoms of 
multiple sclerosis, dysfunction of the lower urinary tract is 
frequent. The incidence is approximately 96% in patients 
with a disease duration of greater than 10 years3"5 but even 
among patients with a short disease duration without mic­
turition complaints 52% had lower urinary tract dysfunc­
tion.6 Some physicians reported micturition complaints as 
being the sole initial symptom of multiple sclerosis in 2% of 
all patients,3»7 while others did not note this finding.8
The discrepancy between clinical manifestations and ana­
tomical lesions in multiple sclerosis is well documented.9 In 
the case of micturition complaints, a poor correlation was 
found between symptoms and the underlying pathophysio­
logical condition.3-10 In most studies, however, the urological 
abnormalities were not related to the severity or state of 
disability of multiple sclerosis. Only a few investigators stud­
ied this relationship by comparing urodynamic features with 
disease duration, physical examination, neurophysiology or 
disability status.3’5’s*n ~15 There were few patients in these 
latter studies (24 to 86), except in the study by Bradley,5 and 
nearly all patients had severe multiple sclerosis.
We evaluated 212 patients with definite multiple sclerosis 
who underwent a complete urological and neurological diag­
nostic evaluation. We examined the relationship between 
urological features and multiple sclerosis features, that is 
disease activity, disease duration, expanded disability status 
scale and neurophysiological abnormalities in these patients.
Accepted for publication December 16, 1994.
MATERIALS AND METHODS
Between January 1989 and December 1992, 212 patients 
with a confirmed diagnosis of multiple sclerosis according to 
the criteria of Poser et al16 were evaluated. Mean age was 
35,9 ± 9.4 years (standard deviation, range 16 to 67) for the 
129 female patients and 38.9 ± 10.5 years (range 18 to 64) for 
the 73 men*
Neurological investigations were performed by 1 neurolo­
gist (O. R. H.). After a thorough history was obtained and 
physical examination performed, the disability was estab­
lished according to the Kurtzke expanded disability status 
scale.17 Based on this scale, patients were divided in 8 groups 
(table 1). Disease duration intervals in all patients (4 groups) 
were chosen so that there was an equal distribution of pa­
tients in each group. Cerebrospinal fluid was investigated 
and the amount of myelin basic protein is presented, since 
values of cerebrospinal fluid-myelin basic protein are consid­
ered indicative of the demyelinating activity of the disease,18 
Cerebrospinal fluid-myelin basic protein values of 1.5 ¡igA . 
or less were considered normal, while all values greater than
1.5 jxg./I. were considered abnormal. A distinction was made 
between twice the normal value and more than twice the 
normal value. Therefore, 3 groups were formed regarding 
cerebrospinal fluid-myelin basic protein: group 1—myelin 
basic protein of 1.5 fig A, or less, group 2—myelin basic 
protein greater than 1.5 to 3.0 ju.g./l. and group 3—myelin 
basic protein greater than 3.0 ju,g./L
Urological investigations consisted of history and physical 
examinations. Patient complaints were classified as irritative 
(urgency, frequency, nocturia and pain), obstructive (hesitation, 
interrupted or weak urine flow and sensation of residual urine) 
and urinary incontinence (involuntary loss of urine). Urody­
namic as well as neuro-urophysiological investigations were 
performed in all patients. Urodynamic investigation was per­
formed according to the standards of the International Conti­
nence Society except when specifically noted.19 Five days before
1 ßÜ
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Table 1. Patient distribution
No, Pts,
Disease duration (mos.):
I to  18 54
19 to 48 51
49 to 108 53
109 or more 54
Expanded disability status scale:
1 25
2 53
3 46
4 25
5 12
6 19
7 27
8 5
Concentration of myelin basic protein in cerebrospinal fluid:
Group 1 169
Group 2 21
Group 3 21
Neurophysiological investigation;
Group 1 48
Group 2 36
Group 3 63
Group 4 53
the urodynamic investigation the patient stopped taking drugs 
that could influence bladder and urinary sphincter behavior. 
Urodynamic tests consisted of urethral pressure profile meas­
urements and cystometry with water at 37C and a filling rate of 
35 ral. per minute through a 12F silicone catheter with the 
patient in the supine position. Pressure-flow analysis was per­
formed on a flow chair after cystometry. Intravesical and ab­
dominal pressures were measured with 6F micro-tip transducer 
catheters. Pelvic floor electromyography was recorded during 
cystometry with a bipolar wire electrode in the anal sphincter or 
2 surface electrodes attached in the vicinity of the anal sphinc­
ter. During cystometry special attention was paid to first desire 
to void and maximal cystometric capacity. A first desire to void 
of200 ml. or greater in combination with a maximum cystomet­
ric capacity of 500 ml. or more was considered pathological 
(hyposensitive). In contrast, a first desire to void of 50 ml. or less 
was considered hypersensitive. Involuntary detrusor contrac­
tions with an intravesical pressure increase of more than 15 cm. 
water during cystometry were considered hyperactive. At the 
end of cystometry a pressure-flow measurement was per­
formed. Residual urine was measured by catheterization before 
and after urodynamic investigation. Residual urine volumes of 
more than 100 ml. and a detrusor contraction with a maximal 
pressure increase of less than 50 cm. water in combination with 
a maximum flow of 12 ml. per second or less were considered 
pathological (hypoactive). Involuntary contraction of the exter­
nal sphincter (increased electromyographic activity) during a 
detrusor contraction was considered detrusor external sphinc­
ter dyssynergia. A residual urine volume of more than 100 ml. 
in combination with a maximum flow rate of 12 ml. per second 
or less, a maximum detrusor contraction of more than 50 cm. 
water and absence of detrusor external sphincter dyssynergia 
were considered to indicate obstruction. The upper urinary 
tract was evaluated by ultrasound of the kidneys or excretory 
urography.
In every patient cortical somatosensory evoked potentials 
and sacral reflex latency measurements were obtained ac­
cording to a previously described technique.20 Somatosensory 
evoked potentials were obtained with bipolar stimulation 
(minimum of 200 stimuli) of the posterior tibial nerve at the 
ankle of the right foot and the dorsal penile or clitoral nerve 
on the dorsum of the shaft of the penis or on the clitoris. To 
measure sacral reflex latencies, a concentric needle electrode 
was inserted in the right upper quadrant of the external anal 
sphincter muscle with the patient in the lithotomy position. 
The electromyographic activity of the anal sphincter after 
insertion of the needle was used to adjust the needle position.
Two stimulation sites were used: the pudendal nerve was 
stimulated at the penis or clitoris and the proximal urethra 
was stimulated through a special balloon catheter with 2 ring 
electrodes, 10 and 20 mm. from the base of the balloon. The 
catheter was inserted into the bladder and retracted after 
filling the balloon, thus allowing for direct electrical stimu­
lation of the mucosa of the proximal urethra. The response 
obtained from the pudendal nerve was recorded as the bul- 
bocavernosus reflex and that obtained from the proximal 
urethra was the urethro-anal reflex. From each reflex, at 
least 8 recordings were performed in each patient. If the 
measurement of a sacral reflex latency (bulboca vernos us or 
urethro-anal reflex) revealed a delayed or not obtainable 
response, the electromyographic needle was relocated and 
the recording was repeated.
Normal and pathological outcomes of the neuro-urophysi- 
ological investigations were distinguished by using the mea­
surements gathered in healthy volunteers.6 For the purpose 
of this study, 4 groups were formed from the neurophysiolog­
ical results: group 1—normal penile/clitoral evoked poten­
tials and sacral reflex latencies, group 2—normal penile/ 
clitoral evoked potentials and abnormal sacral reflex 
latencies, indicating abnormalities at the level of the conus 
medullar is, group 3—abnormal penile/clitoral evoked poten­
tials and normal sacral reflex latencies, indicating suprasa- 
crai abnormalities and group 4—abnormal penile/clitoral 
evoked potentials and sacral reflex latencies, indicating su- 
prasacral abnormalities at the level of the conus medullaris 
(table 1).
For statistical analysis, chi-square tests and the Kruskal- 
Wallis test were used to compare the data for significant 
difference among different groups. For pair wise compari­
sons, the Wilcoxon 2-sample test was used. Test results were 
considered statistically significant if p values were êî0,05.
RESULTS
The overall mean duration of disease was 78.3 ± 83,2 
months (range 2 to 528, mean 77.8 months for men and 78.6 
months for female patients). Table 1 summarizes the group 
distributions regarding multiple sclerosis classification pa­
rameters of disease duration, disability status, cerebrospinal 
fluid-myelin basic protein concentration and neurophysiolog­
ical results. Gender differences among the groups regarding 
the aforementioned classification parameters were not sta­
tistically significant.
Of the 212 patients 111 had micturition complaints (table 
2). Obstruction complaints were found more frequently in 
men than in women and incontinence complaints were more 
frequent in women. Irritative complaints were found equally 
among the sexes, Of the patients 23 had only irritative, 21 
only obstruction and 5 only incontinence complaints. The 
combination of incontinence and irritative complaints was 
noted in 3 patients, obstruction and incontinence complaints 
in 4, obstruction and irritative complaints in 12 and all 
groups of complaints in 21. Urinary tract infections recurred 
in 25 patients.
The urodynamic investigation was abnormal in 136 pa­
tients. Table 3 summarizes the distribution of the urody­
namic abnormalities found. Gender differences were remark­
able: hyper sensibility, hyposensibility and hypo activity were 
more frequent in female than in male patients. Hyperactiv-
Table 2. Micturition complaints
Total No. 
(%)
No. Men
m
No. Women
(%)
Total with complaints 111(52) 42 (58) 69 (50)
Irritative 81 (38) 27 (37) 54 (39)
Obstructive 58 (27) 28 (38) 30 (22)
Incontinence 55 (26) 15 (21) 40 (29)
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Table 3. Urodynamic investigation
Total No.
(%)
No. Men
m
No. Women
m
Total abnormal 136(64) 51 (70) 85 (61)
Detrusor hypersensibility 16 (8) 3 (4) 13 (9)
Detrusor hyposensibility 43 (20) 13 (18) 30 (22)
Detrusor hyperactivity 72(34) 33(45) 39 (28)
Detrusor hypoactivity 32 (8) 9(12) 23 (17)
Detrusor external sphincter 27 (13) 12(16) 15 (11)
dyssynergia
Obstructive 10 (5) 6 (8) 4 (3)
ity, detrusor external sphincter dyssynergia and obstruction 
were more frequent in men. Dilatation of the upper urinary 
tract was found in 2 patients (0.9%). Of the patients without 
micturition complaints 51% had an abnormal urodynamic 
investigation, compared to 81% of patients with irritative, 
obstruction and incontinence complaints.
Ne uro-uro physiological investigations were performed in 
all patients but in 12 at least 1 of the tests could not be done 
because of technical or patient related problems. All tests 
were normal in 43 of the remaining 200 patients (22%). The 
penile/clitoral evoked potentials were abnormal in 58% of the 
patients and the tibial evoked potentials were abnormal in 
46%. Normal tibial evoked potentials plus abnormal penile/ 
clitoral evoked potentials were found in 36 patients (17%) 
and abnormal tibial evoked potentials plus normal penile/ 
clitoral evoked potentials were found in 10 (5%), The latter 
patients had multiple sclerosis plus polyneuropathy. The 
bulbo cavemos us reflex was abnormal in 31% of the patients 
and the urethro-anal reflex was abnormal in 37%.
Disease duration. Table 4 shows that disease duration is 
not related to the urological complaints. The same is true for 
some of the urodynamic abnormalities (fig. 1). Hyposensibil- 
ity is not related to disease duration. Hypers en sib il ity, hy­
peractivity, detrusor external sphincter dyssynergia and 
hypo activity are related to disease duration.
Disability status. Table 4 also shows that urological com-
Table 4. Micturition complaints in relation to parameters
analyzed
Micturition Complaints % 
Irritative Obstructive Incontinence
1-18 30 17 17
19-48 31 31 24
49-108 40 25 34
109 + 52 35 30
p Value 0.07 0,11 0.19
Expanded disability status
score:
1 16 16 8
2 15 32 21
3 22 24 11
4 32 48 20
5 42 75 58
6 26 58 32
7 52 52 59
8 80 60 60
p Value 0.001* 0.002* 0.001*
Cerebrospinal fluid-myelin
basic protein analysis:
Group 1 38 24 24
Group 2 33 33 29
Group 3 38 47 38
p Value 0.90 0.06Î 0.34
Neurophysiological
investigation:
Group 1 25 13 2
Group 2 36 14 28
Group 3 52 44 41
Group 4 40 30 32
p Value 0.03* 0.001* 0.001*
* p ëO.OS.
t  p =0.06, nearly statistically significant.
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Fig. 1. Relationship between urodynamic abnormalities and dis­
ease duration. HRS, hypersensibility (p = 0.02). H O S , hyposensibil- 
ity (p = 0*30). HR A, hyperactivity (p — 0.001). COMt combination of 
hyperactivity and hypoactivity, H O A , hypoactivity (p = 0.007). DSD, 
detrusor-sphincter dyssynergia (p = 0.02).
plaints are well related to the expanded disability status 
scale. In case of urodynamic abnormalities only hyperactiv­
ity, hypoactivity and detrusor external sphincter dyssynergia 
were statistically significantly related to the expanded dis­
ability status scale (fig. 2).
Cerebrospinal fluid-myelin basic protein. Only urological 
complaints of obstruction were nearly statistically related to 
the cerebrospinal fluid-myelin basic protein parameters. For 
the urodynamic abnormalities, only hyperactivity and detru­
sor external sphincter dyssynergia were statistically related 
(fig. 3). Hypersensibility, hyposensibility and hypoactivity 
were not statistically related to cerebrospinal fluid-myelin 
basic protein.
Neuro-urophysiological investigations. Urological com­
plaints were statistically related to the outcome of neuro­
physiological investigations. From the urodynamic abnor­
malities hyperactivity, hypoactivity and detrusor external 
sphincter dyssynergia were statistically related to the out­
come of the neuro-urophysiological investigations (fig. 4).
Obstruction as a urodynamic abnormality was found in 6 
men and 4 women, and was not statistically related to any of 
the multiple sclerosis parameters. A total of 42 patients had 
residual urine levels of more than 100 ml. after voiding (9 did
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Fig. 2 . Relationship between urodynamic abnormalities and ex­
panded disability status scale. H R S,  hypersensibility (p -  0.15). 
H O S , hyposensibility (p = 0.10). H R A , hyperactivity (p = 0.0001). 
COM , combination of hyperactivity and hypoactivity. HOA, hypoac­
tivity (p = 0.0001). D SD t detrusor-sphincter dyssynergia (p = 0.001).
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Fig. 3, Relationship between urodynamic abnormalities and cere­
brospinal fluid-myelin basic protein (CSF-MBP) analysis. HRS> hy­
persensibility (p ~ 0.71). H O S , hyposensibility (p = 0.31). H R A , 
hyperactivity (p = 0.01), COM, combination of hyperactivity and 
hypoactivity. H O A , hypoactivity (p = 0,61), DSD, detrusor-sphincter 
dyssynergia (p = 0.05).
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Fig. 4, Relationship between urodynamic abnormalities and neu­
rophysiological investigation (NUPHD , H R S , hypersensibility (p =  
0.88). HOS, hyposensibility (p -  0,71). HRA, hyperactivity (p -  
0.0001). COM, combination of hyperactivity and hypoactivity. H O A , 
hypoactivity (p = 0.007). DSD, detrusor-sphincter dyssynergia (p =  
0.002).
not have micturition complaints). The amount of residual 
urine after voiding ranged from 100 to 800 ml. Of the pa­
tients with residual urine 11 were not classified as having a 
hypo active urodynamic abnormality.
DISCUSSION
In young adults multiple sclerosis is the most recurrent 
invalidating progressive neurological disease. The risk of 
multiple sclerosis increases as the region extends further 
from the equator in the northern and southern hemisphere.21 
The prevalence in the United States is 41 per 100,000 and in 
the Netherlands it is 60 to 80 per 100,000,21,22 Neurologists 
are mainly responsible for the treatment of multiple sclerosis 
patients but in case of urological complaints or abnormalities 
the help of a urologist will be indispensable. Since 1989, 
patients with multiple sclerosis admitted to the department 
of neurology were also screened at the neurourological unit, 
which provided epidemiological data of urological abnormal­
ities in these patients, and enabled us to study the relation­
ship among different clinical, urological and other related 
parameters of multiple sclerosis.
Our patients represent a cross section through the popii' 
lation of multiple sclerosis patients seen at a multiple scle­
rosis clinic of a university hospital. Micturition complaints 
were found in 52% of the patients. Irritative complaints were 
more frequent than incontinence and obstruction complaints, 
which is in concordance with other reports.3’5,11’15 Micturi­
tion complaints were not statistically related to disease du­
ration, which was also reported by Miller et al.7 However, 
Awad et al reported a positive relationship between disease 
duration and complaints.11 Our finding indicates that multi­
ple sclerosis patients with a short disease duration can suffer 
from serious micturition problems. On the other hand, mic­
turition complaints were related to the disability status, 
which has been reported by others as well.7’8-11 More than 
half of the patients with a Kurtzke score of greater than 4 
suffered from irritative and incontinence complaints. How­
ever, irritative and incontinence complaints did not correlate 
with the cerebrospinal fluid-myelin basic protein analysis. 
Obstruction complaints almost correlated with this analy­
sis, indicating that during an exacerbation of multiple scle­
rosis, when myelin basic protein concentration in the cere­
brospinal fluid increases, the risk of obstruction complaints 
is increased. This finding has been reported by Wheeler et al, 
who stated that because of the characteristic variability of 
the illness therapeutic choices must be adjusted according­
ly.22 Neurophysiology correlated with micturition com­
plaints, in concordance with other reports.3’10 Our data sug­
gest that in multiple sclerosis patients with abnormal 
somatosensory evoked potentials, indicating s pino-cortical 
tract abnormalities, nearly half suffered from obstruction, 
irritative or incontinence urinary complaints. It remains un­
clear why patients with abnormal somatosensory evoked po­
tentials and abnormal sacral reflex latencies, indicating 
spino-cortical tract abnormalities and abnormalities at the 
level of the conus medullaris, suffer fewer complaints than 
those with only somatosensory evoked potential abnormali­
ties. This finding probably results from changes in the neural 
organization at the level of the sacral micturition center, 
which is also encountered in spinal cord injury patients.23
Detrusor hyperactivity was the most frequent urodynamic 
abnormality in our study and was noted in nearly a quarter 
of all patients with urodynamic abnormalities. These results 
are comparable with those reported by others.3' 5' 7 Except for 
hypoactivity, which was not related to cerebrospinal fluid- 
myelin basic protein analysis, abnormalities of detrusor 
activity were statistically related with disease duration, 
disability status, cerebrospinal fluid-myelin basic protein 
analysis and neurophysiology. The same finding was true 
for detrusor-sphincter dyssynergia. Of the multiple sclero­
sis patients with a disease duration of greater than 9 years 
nearly 60% suffered from detrusor activity abnormalities, 
compared to 100% of those with a severe disability status, 
Patients with an exacerbation of multiple sclerosis, result­
ing in elevated cerebrospinal fluid-myelin basic protein 
concentration, are at risk for detrusor hyperactivity.
Somatosensory evoked potentials are a widely used and 
accepted instrument for the evaluation of the function of 
certain pathways within the nervous system in multiple scle­
rosis. Unfortunately, no single neurophysiological test can 
measure the entire spinobulbar-spinal micturition reflex be­
cause it contains sensory and motor pathways. The pudendal 
evoked potential measures a part of the spinobulbar-spinal 
micturition reflex, that is the conductivity of the sensory 
portion of the pudendal nerves and the posterior columns. 
Studies on the usefulness of neurophysiological measure­
ments in the evaluation of the lower urinary tract in multiple 
sclerosis are contradictory. In our experience the use of these 
tests is limited.24
Hypersensibility of the bladder was statistically signifi­
cantly related with disease duration but no linear relation­
ship was noted. Since no other statistical relationship was
URINARY TRACT ABNORMALITIES IN MULTIPLE SCLEROSIS 173
found, it is reasonable to suggest that sensibility abnormal­
ities of the bladder, as defined in our study, were not related 
with multiple sclerosis, although this has been suggested 
previously,6*25 Changing the definition of hyposensibility, in­
stead of the initial desire to void 300 or 400 ml. and a bladder 
capacity of more than 600 or 700 ml., was not statistically 
related to the disease-related parameters. Moreover, the pu­
dendal evoked potential latency and the tibial evoked poten­
tial latency were not statistically related to initial desire to 
void or bladder capacity. Obviously, bladder sensation meas­
ured by urodynamic investigation is not a good method to 
investigate the conductivity of the posterior columns as re­
ported by others as well.26
In our study only 2 patients (0,9%) presented with upper 
urinary tract abnormalities: in 1 no urodynamic abnormality 
was found, while 1 had severe detrusor hyperactivity and 
detrusor-sphincter dyssynergia. In the literature, the inci­
dence of upper urinary tract abnormalities in multiple scle­
rosis patients is low. In 14 studies (2,076 patients) only 7 
patients were reported to have upper urinary tract abnor­
malities.3-5'7« 8’10’n ’13"15’ 25> 27~29
CONCLUSIONS
Lower urinary tract abnormalities are frequently observed 
in patients with multiple sclerosis. For the urologist it is 
important to realize that every patient with multiple sclero­
sis can suffer from lower urinary tract abnormalities unre­
lated to the duration of the disease or the disability status. 
Since only 1 patient with upper urinary tract abnormalities 
also had urodynamic abnormalities, multiple sclerosis re­
sults in urological morbidity that influences the quality of 
life, rather than causes life threatening upper urinary tract 
conditions as observed in spinal cord injury patients.30
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